TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Vistin Pharma AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
304,124
|
282,820
|
241,656 |
Financial expenses |
11,924
|
7,869
|
22,150 |
Earnings before taxes |
-3,843
|
36,170
|
35,973 |
Total assets |
427,646
|
325,866
|
214,259 |
Current assets |
166,767
|
126,210
|
75,598 |
Current liabilities |
295,074
|
193,908
|
77,552 |
Equity capital |
57,276
|
56,224
|
27,047 |
- share capital |
106
|
103
|
32 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
13.4%
|
17.3%
|
12.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
-1.3%
|
12.8%
|
14.9% |
Return on assets (ROA) |
1.9%
|
13.5%
|
27.1% |
Current ratio |
56.5%
|
65.1%
|
97.5% |
Return on equity (ROE) |
-6.7%
|
64.3%
|
133.0% |
Change turnover |
12,541
|
23,229
|
23,893 |
Change turnover % |
4%
|
9%
|
11% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.